Compare Lattice Semiconductor Corporation Common Stock (LSCC) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lattice Semiconductor Corporation Common Stock vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Lattice Semiconductor Corporation Common Stock trades at $126.05 (market cap $17.76B), while Nuvation Bio Inc. Class A Common Stock trades at $5 (market cap $1.74B). The key difference: Lattice Semiconductor Corporation Common Stock is far larger — about 10.2× Nuvation Bio Inc. Class A Common Stock's market cap, and Lattice Semiconductor Corporation Common Stock is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Lattice Semiconductor Corporation Common Stock for 1 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| LSCC | NUVB | |
|---|---|---|
Market Cap | $17.76B | $1.74B |
Volume | 1,802,283 | 9,289,619 |
Sector | Technology | Health |
52-Week High | $155.27 | $9.54 |
52-Week Low | $61.73 | $3.41 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $17.62B | $1.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Lattice Semiconductor Corporation Common Stock
Lattice Semiconductor develops low-power programmable chips, known as FPGAs. Its products are used in communications, computing, industrial, and automotive applications.
Read more on LSCC →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
